Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer.
Hong DS, Gopal AK, Shoushtari AN, Patel SP, He AR, Doi T, Ramalingam SS, Patnaik A, Sandhu S, Chen Y, Davis CB, Fisher TS, Huang B, Fly KD, Ribas A.
Hong DS, et al. Among authors: chen y.
Front Immunol. 2022 Aug 2;13:897991. doi: 10.3389/fimmu.2022.897991. eCollection 2022.
Front Immunol. 2022.
PMID: 35983060
Free PMC article.